Failure of N-acetylcysteine to protect against cis-dichlorodiammineplatinum(II)-induced hematopoietic toxicity in mice.

[1]  I. Pannacciulli,et al.  The effect of N-acetylcysteine on toxicity of cyclophosphamide and doxorubicin on murine hemopoietic progenitors. , 1985, Life sciences.

[2]  P. Newburger,et al.  Chediak-Higashi syndrome: studies in long-term bone marrow culture. , 1985, Experimental hematology.

[3]  Y. Ohno,et al.  N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat. , 1984, Cancer research.

[4]  J. Weikel,et al.  The toxicity of N-acetylcysteine in laboratory animals. , 1983, Seminars in oncology.

[5]  Z. Pavelic,et al.  Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide. , 1983, Seminars in oncology.

[6]  F. d'Amore,et al.  Hematopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin. , 1982, Journal of the National Cancer Institute.

[7]  A. Sobrero,et al.  Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells. , 1982, Cancer research.

[8]  Priv.-Doz. Dr. Hans-Peter Lohrmann,et al.  Recent Results in Cancer Research , 2011 .

[9]  J. Doroshow,et al.  Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. , 1981, The Journal of clinical investigation.

[10]  M. Weiner,et al.  Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. , 1980, The Journal of pharmacology and experimental therapeutics.

[11]  S. Beckley,et al.  Cisplatin-induced hemolysis. , 1980, The New England journal of medicine.

[12]  J. J. Roberts,et al.  The interaction of antitumour platinum compounds with cellular DNA in cultured cells and animal tissues: relationship to DNA cellular repair processes , 1978 .

[13]  K. Kohn,et al.  Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II). , 1978, Cancer research.

[14]  W. Whitmore,et al.  Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model , 1977, Cancer.

[15]  J. Marsh.  The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. , 1976, Cancer research.

[16]  M. Ogawa,et al.  Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells. , 1975, Cancer research.

[17]  B. Brown,et al.  The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. , 1973, Cancer research.

[18]  G. Gale,et al.  cis-dichlorodiammineplatinum(II): hematopoietic effects in rats. , 1971, Toxicology and applied pharmacology.

[19]  D. Metcalf,et al.  The growth of mouse bone marrow cells in vitro. , 1966, The Australian journal of experimental biology and medical science.

[20]  L. Lajtha,et al.  KINETICS OF A BONE‐MARROW STEM‐CELL POPULATION , 1964, Annals of the New York Academy of Sciences.

[21]  W. Wolf.  Synthesis and distribution of ^ Pt cis-dichlorodiammineplatinum (II) , 1976 .